We are live on ! Find out more
AXGN icon

Axogen

26 hedge funds and large institutions have $16.3M invested in Axogen in 2013 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

8% more funds holding

Funds holding: 2426 (+2)

3% less capital invested

Capital invested by funds: $16.7M → $16.3M (-$426K)

50% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 8

Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.75%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
8
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Alyeska Investment Group
26
Alyeska Investment Group
Illinois
-$666K -150,000 Closed
Wells Fargo
27
Wells Fargo
California
-$54.4K -13,375 -99%
Deutsche Bank
28
Deutsche Bank
Germany
-$15K -3,501 Closed

AXGN Hedge Fund Activity: Q4 2013 in Review

26 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Axogen (AXGN) for Q4 2013, worth a combined $16.3M — down 2.5% from $16.7M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new AXGN positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 8 trimmed.

The largest buyer was Vanguard Group, adding an estimated $332K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $666K sold.

  • 26 institutional investors held Axogen (AXGN) as of Q4 2013, up from 24 in Q3 2013.
  • Funds reported $16.3M of Axogen stock for Q4 2013, down 2.5% quarter-over-quarter.
  • 4 funds opened new Axogen positions in Q4 2013 and 2 closed out, a net change of +2 holders.
  • The largest Axogen buyer in Q4 2013 was Vanguard Group, an estimated $332K added.
  • The largest Axogen seller in Q4 2013 was Alyeska Investment Group, an estimated $666K sold.

Based on aggregated 13F filings for Q4 2013.